Form 4: Select Medical Executive Receives Significant Restricted Stock Grant

Michael E. Tarvin, Executive Vice President of Select Medical Holdings Corp, was granted 100,000 shares of restricted common stock, vesting over three years.

Summary

• Michael E. Tarvin, Executive Vice President of Select Medical Holdings Corp (SEM), was granted 100,000 shares of common stock.
• The transaction date for this acquisition was July 29, 2025.
• The shares were acquired at a price of $0, indicating a grant of restricted stock.
• Following this transaction, Mr. Tarvin beneficially owns 527,760 shares of common stock.
• The restricted stock grant will vest in equal annual installments over a period of three years.

Sentiment

Score: 7

Explanation: The grant of restricted stock to a key executive is generally a positive signal, indicating efforts to align management interests with shareholders and retain talent. The vesting schedule promotes long-term commitment. The minor dilution from the grant is typically outweighed by these benefits.

Positives

• The grant of restricted stock aligns the executive's interests with long-term shareholder value.
• The vesting schedule over three years promotes executive retention and commitment to the company's future performance.
• An increase in insider ownership can signal confidence in the company's prospects.

Negatives

• The issuance of new shares for the grant could lead to minor dilution for existing shareholders, though the impact from 100,000 shares is likely minimal for a publicly traded company.

Future Outlook

The three-year vesting schedule for the restricted stock grant indicates a long-term incentive for the executive, aligning their future performance with the company's success.

Industry Context

Restricted stock grants are a common form of executive compensation in the healthcare services industry, used to attract, retain, and incentivize key management personnel by aligning their financial interests with the company's long-term performance and shareholder value creation.

Comparison to Industry Standards

• Restricted stock grants with multi-year vesting schedules are standard practice across various industries, including healthcare, for executive compensation.
• Companies like HCA Healthcare, Universal Health Services, and Tenet Healthcare frequently utilize similar equity-based incentives to retain top talent and foster long-term strategic alignment.
• The three-year vesting period is a common duration for such grants, balancing immediate incentive with long-term commitment.

Related Party Transactions

• This filing reports an insider transaction, specifically an equity grant to an executive, which is a form of related party dealing.

Stakeholder Impact

• Shareholders: Potential for minor dilution from the issuance of new shares, but also benefit from increased executive alignment with long-term company performance.
• Employees: May signal stability and a commitment to retaining key leadership, potentially boosting morale.
• Management: Directly benefits from the equity grant, providing a significant incentive for long-term performance.

Next Steps

• The restricted stock will vest in equal annual installments over the next three years, starting from the transaction date of July 29, 2025.

Key Dates

Recommendation

This Form 4 filing reports a routine executive compensation event (restricted stock grant) which is generally a positive for long-term alignment and retention. However, it does not contain new financial performance data or strategic shifts that would warrant a change in investment recommendation. It reinforces a "hold" stance as it's a standard operational disclosure rather than a catalyst for significant re-evaluation.

Keywords

Select Medical Holdings Corp, SEM, Michael E. Tarvin, Restricted Stock Grant, Insider Ownership, Executive Compensation, Form 4, SEC Filing, Equity Compensation, Healthcare Services